Regulatory & market intelligence for alternative tobacco & nicotine products
While the Philippines debates regulations to restrict tobacco alternatives, PMFTC, the Philippine affiliate of Philip Morris International (PMI), has opened its first four IQOS stores in the Manila area
All the stories from the TobaccoIntelligence regulatory Live Alerts in one user-friendly database, updated every month.
This regulatory tool consolidates all of our global regulatory Live Alerts, collected in Excel database format, allowing you to filter information by date, region, country and legislative area.
Reynolds American has submitted a premarket tobacco product application (PMTA) to the US Food and Drug Administration (FDA) for its Velo nicotine lozenges to remain on the market after September
KT&G heated tobacco products are available outside South Korea for the first time after Philip Morris International (PMI) began marketing them in Russia
Japan Tobacco International (JTI) is to increase the price of some of its heated tobacco consumables in Japan from 1st October
BAT’s revenue from its smokeless portfolio increased by 5.7% to £9.4bn ($12.3bn) in the first six months of the year, helped by higher revenue in the modern oral segment
Altria has reported net revenue to be down by 3.8% in Q2 2020 due to the decrease of the traditional tobacco business, though a further drop was prevented thanks to the good performance of its smokeless products in the US
The Japanese Consumer Affairs Agency has imposed a fine of JPY552m ($5.1m) on Philip Morris Japan (PMJ) for misleading advertising of IQOS when discounts were extended beyond the allotted date
British American Tobacco (BAT) is pushing back to 2025 its goal of £5bn in revenues from its next-generation portfolio amid the COVID-19 pandemic and a decrease in heat-not-burn (HnB) business
The Altria Group has filed a lawsuit for patent infringement against RJ Reynolds Vapor Co, a subsidiary of Reynolds American, over its Velo smokeless product
Japan Tobacco (JT) and Philip Morris International (PMI) are cutting the prices of their heat-not-burn (HnB) devices in Japan and planning new product launches amid the coronavirus pandemic
Big Tobacco manufacturers are expecting the effects of COVID-19 to hit hard in the second half of the year, despite a strong performance in the first quarter
Swedish Match’s sales of smoke-free products boomed in the first quarter of 2020, with the segment recording a 35% year-on-year increase to SEK2.508bn (€234m)
British American Tobacco is suing Big Tobacco rival Philip Morris International in the US and in Europe for allegedly infringing its patents with its popular heated tobacco device IQOS
Philip Morris International is braced for a significant dip in sales and use of its heated-tobacco device IQOS over the rest of 2020, with retail and travel restrictions currently imposed in nearly every country
The US tobacco industry is resisting another attempt by the FDA to impose graphic health warnings, claiming in a lawsuit that mandatory warnings would violate their rights under the First Amendment
The US International Trade Commission (USITC) is looking into a possible infringement of the patent for a nicotine pouch product, following a claim led by Swedish Match North America
Philip Morris International (PMI)’s chief financial officer, Martin King, has been promoted to the newly created role of CEO for PMI America in a bid to further develop the company’s smoke-free segment
British American Tobacco (BAT)’s “modern oral” portfolio has been one of the main drivers helping the company achieve good results in 2019 for its next-generation products category, which overall increased globally by 36.9%
What benefit might there be in very low nicotine combustible cigarettes? That is the essential question the US FDA must answer in assessing a modified risk tobacco product (MRTP) application from 22nd Century Group for its VLN products
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the TobaccoIntelligence team.
